← Evidence map

ArticlePharmacoEconomics2017

Comment on: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation".

Afschin GandjourPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2017

2018

this papercites it

Comment on: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation". | OpenQuestion